Chemotherapy of bladder cancer: a review.
Cytotoxic chemotherapy is used increasingly in the management of bladder cancer. The agents used, intravesically and systemically, are reviewed, together with preliminary reports of certain trials of adjuvant chemotherapy that have now been activated.
D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005009:Ethoglucid / Q000008:administration & dosage; D005060:Europe; D006801:Humans; D009361:Neoplasm Invasiveness; D011379:Prognosis; D011897:Random Allocation; D013852:Thiotepa / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
D000970:Antineoplastic Agents; D005009:Ethoglucid; D004317:Doxorubicin; D013852:Thiotepa